Luke is a Partner at investment firm Octopus Ventures, one of Europe’s largest venture funds, and as part of the Future of Health investment team, helps to identify and invest in the next generation of companies that will revolutionise the health landscape.
Luke joined Octopus Ventures in 2009 but began his career as a scientist, working to understand human disease using computational methods and big data, revealing the role that evolution played in disease development, before transitioning to Management and Technology Consultancy, specialising in the Capital Markets.
Luke is Chair of the University of Manchester Innovation Factory. He also sits on the University’s Global Leadership Board. Luke holds a BSc [hons] in Biochemistry and Biotechnology, an MSc in Computational Biology and a PhD in Computational Genetics, all from The University of Manchester.